Adjunctive corticosteroids therapy in acute respiratory distress syndrome owing to disseminated coccidioidomycosis.

Abstract

Coccidioides immitis causes a benign upper respiratory tract infection in endemic areas. Acute respiratory distress syndrome is a rare complication that is associated with high mortality. Corticosteroids have been avoided as adjunctive therapy to antifungals in the treatment of acute respiratory distress syndrome secondary to coccidioidomycosis because of the fear of enhancing fungal virulence, but they have been proven safe and effective in other infectious entities. We are presenting a case of severe acute respiratory distress syndrome owing to a fulminant coccidioidomycosis infection that responded to a short course of systemic corticosteroids in addition to the standard antifungal treatment.

• Authors: Muhammad Shibli, Joseph Ghassibi, Rizan Hajal, Mary O'Sullivan
• Journal: Critical care medicine (Crit Care Med) Vol. 30 Issue 8 Pg. 1896-8 (Aug 2002) ISSN: 0090-3493 [Print] United States
• PMID: 12163812 (Publication Type: Case Reports, Journal Article)

Chemical References

• Adrenal Cortex Hormones

Topics

• Acute Disease
• Adrenal Cortex Hormones (therapeutic use)
• Adult
• Coccidioidomycosis (complications, drug therapy)
• Humans
• Male
• Respiratory Distress Syndrome (complications, drug therapy)
• Treatment Outcome